Involuntary Treatment of Psychosis in Pregnancy

J Am Acad Psychiatry Law. 2018 Jun;46(2):217-223. doi: 10.29158/JAAPL.003759-18.

Abstract

When a patient with acute psychosis refuses antipsychotic medication despite a clear need for treatment, involuntary medication is often considered. When the patient is both pregnant and acutely unwell, an additional layer of analysis enters the picture. This analysis then also includes the health of the mother and fetus, rights of the mother and fetus, and whose rights take precedence when choosing treatment options in event of a conflict. Antipsychotic agents are frequently the medications prescribed as involuntary treatment. Typical and atypical antipsychotic agents are often used in both emergent and nonemergent situations during pregnancy. Despite a lack of randomized, double-blind, controlled, prospective studies in pregnancy, available data regarding the safety of antipsychotic agents in pregnancy are relatively reassuring. At the same time, the risks of untreated psychosis, for both the mother and the fetus, are not negligible. Such cases merit ethics-related and legal analyses. Forensic psychiatrists involved in such cases need to consider the patient's capacity to make medical decisions and be able to discuss the potential risks, benefits, and alternatives with patients and in court, as part of initiation of involuntary treatment.

MeSH terms

  • Adult
  • Antipsychotic Agents / therapeutic use
  • Female
  • Humans
  • Involuntary Treatment / legislation & jurisprudence
  • Involuntary Treatment / statistics & numerical data*
  • Maternal Welfare / legislation & jurisprudence
  • Maternal Welfare / statistics & numerical data*
  • Patient Acceptance of Health Care / statistics & numerical data
  • Personal Autonomy*
  • Pregnancy
  • Pregnancy Complications / drug therapy*
  • Psychotic Disorders / drug therapy*
  • Young Adult

Substances

  • Antipsychotic Agents